Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | NT5E | P21589 | 2/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9850142 | 1.00 | BCHE (0.42) | BCHENT5EADORA3SLC29A1ADORA1 | |
| SCHEMBL9850195 | 0.87 | BCHE (0.54) | BCHENT5EADORA3SLC29A1ADORA1 | |
| SCHEMBL9850180 | 0.87 | BCHE (0.42) | BCHENT5EADORA3SLC29A1ADORA1 | |
| SCHEMBL9850201 | 0.87 | BCHE (0.54) | BCHENT5EADORA3SLC29A1ADORA1 | |
| SCHEMBL21393155 | 0.87 | TYMP (0.43) | BCHENT5ESLC29A1ADORA1EGFR | |
| SCHEMBL21367453 | 0.84 | SLC29A1 (0.43) | BCHENT5ESLC29A1ADORA1EGFR | |
| SCHEMBL8621084 | 0.84 | SLC29A1 (0.43) | BCHENT5ESLC29A1ADORA1EGFR | |
| SCHEMBL12580037 | 0.84 | SLC29A1 (0.43) | BCHENT5ESLC29A1ADORA1EGFR | |
| SCHEMBL8621079 | 0.84 | SLC29A1 (0.43) | BCHENT5ESLC29A1ADORA1EGFR | |
| SCHEMBL9850194 | 0.80 | NT5E (0.49) | NT5EADORA3SLC29A1ADORA1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0428109-A2 | Deoxyfluoronucleoside process | Bristol-Myers Squibb Company (US) | 1991-05-22 | — | — | EP | disclosed |